Equillium Company Insiders
EQ Stock | USD 0.75 0.03 3.85% |
Equillium's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Equillium suggests that virtually all insiders are panicking. Equillium employs about 45 people. The company is managed by 11 executives with a total tenure of roughly 21 years, averaging almost 1.0 years of service per executive, having 4.09 employees per reported executive.
Daniel Bradbury Chairman Chairman of the Board, CEO |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-01-23 | Jason A Keyes | Disposed 10000 @ 0.65 | View | ||
2024-11-14 | Jason A Keyes | Disposed 10000 @ 0.7 | View | ||
2024-10-28 | Penny Tom | Disposed 2835 @ 1.25 | View | ||
2024-10-25 | Penny Tom | Disposed 683 @ 1.25 | View | ||
2024-09-26 | Jason A Keyes | Disposed 10000 @ 0.81 | View | ||
2024-09-16 | Penny Tom | Disposed 38806 @ 0.85 | View | ||
2024-07-16 | Jason A Keyes | Disposed 10000 @ 0.87 | View |
Monitoring Equillium's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Equillium |
Equillium Management Team Effectiveness
The company has Return on Asset (ROA) of (0.0944) % which means that for every 100 dollars spent on asset, it generated a loss of $0.0944. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.1952) %, which implies that it produced no returns to current stockholders. Equillium's management efficiency ratios could be used to measure how well Equillium manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/17/2025, Return On Tangible Assets is likely to drop to -0.32. In addition to that, Return On Capital Employed is likely to drop to -0.76. At this time, Equillium's Total Current Liabilities is relatively stable compared to the past year. As of 03/17/2025, Liabilities And Stockholders Equity is likely to grow to about 67.5 M, while Non Current Liabilities Total is likely to drop slightly above 419.5 K.As of 03/17/2025, Common Stock Shares Outstanding is likely to drop to about 25.8 M. In addition to that, Net Loss is likely to grow to about (53.4 M)
Equillium Workforce Comparison
Equillium is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,326. Equillium holds roughly 45.0 in number of employees claiming about 3% of equities under Health Care industry.
Equillium Profit Margins
The company has Net Profit Margin (PM) of (0.1) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.06) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.06.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.79 | 0.9 |
|
|
Equillium Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Equillium insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Steel Bruce D. over three weeks ago Disposition of 100000 shares by Steel Bruce D. of Equillium at 4.75 subject to Rule 16b-3 | ||
Troupin Barbara over a month ago Disposition of 40000 shares by Troupin Barbara of Equillium at 3.59 subject to Rule 16b-3 | ||
Jason Keyes over a month ago Disposition of 10000 shares by Jason Keyes of Equillium at 0.65 subject to Rule 16b-3 | ||
Penny Tom over two months ago Acquisition by Penny Tom of 125000 shares of Equillium at 0.77 subject to Rule 16b-3 | ||
Colabuono Peter over three months ago Acquisition by Colabuono Peter of 40000 shares of Equillium at 0.7 subject to Rule 16b-3 | ||
Colabuono Peter over three months ago Insider Trading | ||
Daniel Bradbury over three months ago Acquisition by Daniel Bradbury of 38000 shares of Equillium at 3.59 subject to Rule 16b-3 | ||
Jason Keyes over three months ago Disposition of 10000 shares by Jason Keyes of Equillium at 0.7 subject to Rule 16b-3 |
Equillium Notable Stakeholders
An Equillium stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Equillium often face trade-offs trying to please all of them. Equillium's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Equillium's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel Bradbury | Chairman of the Board, CEO | Profile | |
Bruce CFA | President, CoFounder | Profile | |
PMP MBA | Senior COO | Profile | |
Stephen Connelly | Chief Scientific Officer, Director | Profile | |
Jason Keyes | Chief Officer | Profile | |
Matthew Ritter | Senior Development | Profile | |
Penny Tom | Principal Officer | Profile | |
Maple MD | Chief Officer | Profile | |
Krishna MD | Consultant | Profile | |
Joel Rothman | Chief Officer | Profile | |
Michael Moore | Vice Communications | Profile |
About Equillium Management Performance
The success or failure of an entity such as Equillium often depends on how effective the management is. Equillium management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Equillium management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Equillium management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.30) | (0.32) | |
Return On Capital Employed | (0.73) | (0.76) | |
Return On Assets | (0.30) | (0.32) | |
Return On Equity | (0.68) | (0.71) |
Equillium Workforce Analysis
Traditionally, organizations such as Equillium use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Equillium within its industry.Equillium Manpower Efficiency
Return on Equillium Manpower
Revenue Per Employee | 801.9K | |
Revenue Per Executive | 3.3M | |
Net Loss Per Employee | 296.3K | |
Net Loss Per Executive | 1.2M | |
Working Capital Per Employee | 483.9K | |
Working Capital Per Executive | 2M |
Additional Tools for Equillium Stock Analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.